Consolidated Statements of Operations (USD $)
In Thousands, unless otherwise specified
 2 Months Ended 10 Months Ended 12 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended 10 Months Ended
Dec. 31, 2011
Nov. 03, 2011
Dec. 31, 2012
Dec. 31, 2011
Successor [Member]
Dec. 31, 2013
Successor [Member]
Sep. 30, 2013
Successor [Member]
Jun. 30, 2013
Successor [Member]
Mar. 31, 2013
Successor [Member]
Dec. 31, 2012
Successor [Member]
Sep. 30, 2012
Successor [Member]
Jun. 30, 2012
Successor [Member]
Mar. 31, 2012
Successor [Member]
Dec. 31, 2013
Successor [Member]
Dec. 31, 2012
Successor [Member]
Nov. 03, 2011
Predecessor [Member]
Revenue:                              
Rental       $ 142,962                 $ 750,252 $ 822,201 $ 746,816
Sales       161,802                 1,008,659 924,252 756,596
Total revenue       304,764 469,787 440,561 432,679 415,884 439,932 435,873 438,115 432,533 1,758,911 1,746,453 1,503,412
Rental expenses       85,142                 358,595 443,446 350,912
Cost of sales       43,761                 261,569 249,338 190,927
Gross profit       175,861 304,809 288,664 282,972 262,302 285,989 276,450 251,864 239,366 1,138,747 1,053,669 961,573
Selling, general and administrative expenses       217,717                 696,175 602,781 565,512
Research and development expenses       14,117                 75,624 71,859 69,601
Acquired intangible asset amortization       16,459                 188,571 220,984 29,519
Impairment of goodwill and intangible assets 0 0 0 0                 443,400 [1] 0 0
Operating earnings (loss)       (72,432) 58,180 (369,866) 11,131 35,532 62,092 66,563 26,797 2,593 (265,023) 158,045 296,941
Interest income and other       148                 1,602 829 972
Interest expense       (105,052)                 (419,877) (466,622) (61,931)
Loss on extinguishment of debt       0                 (2,364) (31,481) 0
Foreign currency gain (loss)       21,783                 (22,226) (13,001) 131
Derivative instruments gain (loss)       (9,473)                 1,576 (31,433) (2,909)
Earnings (loss) from continuing operations before income taxes (benefit)       (165,026)                 (706,312) (383,663) 233,204
Income tax expense (benefit)       (46,330)                 (150,957) (150,048) 74,367
Earnings (loss) from continuing operations       (118,696) (51,731) (398,306) (61,947) (43,371) (56,171) (37,844) (54,602) (84,998) (555,355) (233,615) 158,837
Earnings (loss) from discontinued operations, net of tax       3,827 (1,004) (255) (628) (1,416) 95,878 2,032 (32) (5,680) (3,303) 92,198 32,101
Net earnings (loss)       $ (114,869) $ (52,735) $ (398,561) $ (62,575) $ (44,787) $ 39,707 $ (35,812) $ (54,634) $ (90,678) $ (558,658) $ (141,417) $ 190,938
[1] The period from January 1 through November 3, 2011 includes amortization of acquired intangible assets related to our purchase of LifeCell in May 2008. The years ended December 31, 2013 and 2012 and the period from November 4 through December 31, 2011includes amortization of acquired intangible assets related to our Merger in November 2011.